Comparison of Dienogest and Continuous Combined Oral Contraceptive Pills Effects on Pain, Quality of Life, and Endometrioma Recurrence after Surgery for Endometriosis: A randomized Controlled Trial

Maryam Hashemi
2021 · doi:10.17632/k2ffd6j5zj.1 · W6962616091
RCT OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-21 ⓘ

This randomized trial found that both dienogest and combined oral contraceptive pills significantly improved pelvic pain and quality of life in women with endometriosis after surgery, with no significant difference between treatments regarding endometrioma recurrence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This randomized controlled trial compared the efficacy of dienogest versus continuous combined oral contraceptive pills in managing postoperative outcomes for women with surgically confirmed endometriosis. The study enrolled eighty patients who received either medication daily for six months following laparoscopic conservative surgery, assessing changes in pelvic pain, quality of life, and endometrioma recurrence. Results indicated that both treatments significantly improved self-reported pain levels and quality of life scores, with no statistically significant differences observed between the two groups regarding symptom relief or recurrence rates. This paper is centrally about endometriosis — specifically evaluating medical management strategies to reduce pain and prevent endometrioma recurrence after surgical intervention.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Study objective: To compare the effects of dienogest and combined oral contraceptive (COC) pills after laparoscopic conservative surgery on pain, quality of life (QOL), and recurrence of endometrioma in women with endometriosis. Design: Prospective randomized clinical trial study. Setting: Academic tertiary referral center. Patients: Women with endometriosis confirmed by surgery from April 2016 to June 2018. Interventions: Eighty patients who had undergone operative laparoscopy received dienogest or COC pills daily for six months. Measurements and Main Results: Treatment with dienogest was associated with improved self-reported of all types of pelvic pain and QOL after 6 months of treatment (P < 0.05). Improvement of these parameters was also observed in COC groups (P < 0.05), except for dyspareunia (p=0.089). Both of these pills significantly improved the scores of QOL and sexual function, but no remarkable differences were detected between the two groups in this regard (P < 0.05). About recurrence of endometrioma, there were no differences between dienogest and COC users (p=0.1). Conclusion: Postoperative administration of dienogest or COC pills after operative laparoscopy reduced pain and improved QOL in women with endometriosis. So, the choice of regimen can be adjusted according to the patientʼs symptoms, needs, and preferences. Keywords: Dienogest; Combined Oral Contraceptive; Endometriosis; Surgery; Pelvic Pain; Quality of Life
Full text 1,737 characters · extracted from oa-html · click to expand
Comparison of Dienogest and Continuous Combined Oral Contraceptive Pills Effects on Pain, Quality of Life, and Endometrioma Recurrence after Surgery for Endometriosis: A randomized Controlled Trial Description Abstract Study objective: To compare the effects of dienogest and combined oral contraceptive (COC) pills after laparoscopic conservative surgery on pain, quality of life (QOL), and recurrence of endometrioma in women with endometriosis. Design: Prospective randomized clinical trial study. Setting: Academic tertiary referral center. Patients: Women with endometriosis confirmed by surgery from April 2016 to June 2018. Interventions: Eighty patients who had undergone operative laparoscopy received dienogest or COC pills daily for six months. Measurements and Main Results: Treatment with dienogest was associated with improved self-reported of all types of pelvic pain and QOL after 6 months of treatment (P < 0.05). Improvement of these parameters was also observed in COC groups (P < 0.05), except for dyspareunia (p=0.089). Both of these pills significantly improved the scores of QOL and sexual function, but no remarkable differences were detected between the two groups in this regard (P < 0.05). About recurrence of endometrioma, there were no differences between dienogest and COC users (p=0.1). Conclusion: Postoperative administration of dienogest or COC pills after operative laparoscopy reduced pain and improved QOL in women with endometriosis. So, the choice of regimen can be adjusted according to the patientʼs symptoms, needs, and preferences. Keywords: Dienogest; Combined Oral Contraceptive; Endometriosis; Surgery; Pelvic Pain; Quality of Life Files Institutions - Isfahan University of Medical Sciences

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometriomadyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T03:52:31.725103+00:00
License: CC0 · commercial use OK